<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00655681</url>
  </required_header>
  <id_info>
    <org_study_id>07-213</org_study_id>
    <nct_id>NCT00655681</nct_id>
  </id_info>
  <brief_title>Prevention of Post Operative Bone Loss in Children</brief_title>
  <official_title>Prevention of Post Operative Bone Loss in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of New Mexico</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Thrasher Research Fund</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of New Mexico</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis: one-dose pamidronate will prevent post-operative bone loss in children at risk
      for low bone density

      Plan: children with chronic disease such as CP, spina bifida, etc. will be recruited pre
      operatively and studied with DXA scan. After surgery, children will be randomized to receive
      either pamidronate or saline. Repeat DXA scan will determine bone lost after end of
      immobilization or nonweightbearing.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children at risk for post operative bone loss will be studied with preoperative DXA scan of
      spine and distal femora

      Preoperative screening with standard labs electrolytes, Ca++, PO4, creatinine, Vit D

      Following surgery of hip(s) or lower extremities, randomization into treatment with low dose
      IV pamidronate (one dose) v placebo group

      Repeat DXA scan after end of immobilization or non-weightbearing
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2007</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">August 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Amount of bone density lost (%) from pre-to post-operative DXA scan</measure>
    <time_frame>Preoperative to post-operative DXA scan (4-12 weeks)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post operative fractures of lower extremity</measure>
    <time_frame>1 year post operatively</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Osteoporosis</condition>
  <condition>Cerebral Palsy</condition>
  <condition>Spina Bifida</condition>
  <condition>Osteopenia</condition>
  <condition>Osteogenesis Imperfecta</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives pamidronate 1mg/kg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>receives saline injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>pamidronate</intervention_name>
    <description>The pamidronate is mixed 1 to 10 (10 cc of saline for each 1 mg pamidronate), with a minimum volume of 50 cc saline. The medication is administered as an IV infusion to run at a rate beginning at 20 cc/hr, adjusting the rate so that the infusion will run over 4 hours. For children &lt; 8 kg (80cc infusion), the rate would be 20 cc/hr and the duration would be determined by the volume.</description>
    <arm_group_label>A</arm_group_label>
    <other_name>Aredia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>receives saline 10cc/kg over 4 hours post operatively in addition to routine post operative fluids</description>
    <arm_group_label>B</arm_group_label>
    <other_name>normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  chronic condition predisposing to low bone density, such as cerebral palsy,
             osteogenesis imperfecta

          -  lower extremity surgery proposed that will require post op nonweightbearing, casted or
             not, for a minimum of 4 weeks

        Exclusion Criteria:

          -  creatinine &gt;1.2

          -  prior bisphosphonate exposure

          -  orthopaedic implants in distal femoral precluding DXA scan

          -  inability to cooperate with DXA scan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elizabeth A Szalay, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of New Mexico Carrie Tingley Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of New Mexico Carrie Tingley Hospital</name>
      <address>
        <city>Albuquerque</city>
        <state>New Mexico</state>
        <zip>87102</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 4, 2008</study_first_submitted>
  <study_first_submitted_qc>April 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 10, 2008</study_first_posted>
  <last_update_submitted>February 29, 2012</last_update_submitted>
  <last_update_submitted_qc>February 29, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 1, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of New Mexico</investigator_affiliation>
    <investigator_full_name>Elizabeth Szalay</investigator_full_name>
    <investigator_title>Professor, Pediatric Orthopaedics &amp; Pediatrics</investigator_title>
  </responsible_party>
  <keyword>pediatric osteoporosis</keyword>
  <keyword>pediatric osteopenia</keyword>
  <keyword>pamidronate</keyword>
  <keyword>post operative osteopenia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoporosis</mesh_term>
    <mesh_term>Cerebral Palsy</mesh_term>
    <mesh_term>Bone Diseases, Metabolic</mesh_term>
    <mesh_term>Osteogenesis Imperfecta</mesh_term>
    <mesh_term>Spinal Dysraphism</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>February 3, 2014</submitted>
    <returned>March 15, 2014</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

